Farhat Nasim

Mounjaro has rapidly gained popularity in India, becoming the second-biggest drug by sales within just six months, with Rs 233 cro...Go to article

Intas Pharma has been instructed to narrow its profit margins and extend the duration of its clinical trial protocol for Pembroliz...Go to article

Sanofi has announced a significant investment of USD 625 million into Sanofi Ventures, aimed at enhancing biotech and digital heal...Go to article

Alembic Pharma has received approval from the USFDA for its generic version of Paxil CR tablets, which is used to treat depression...Go to article

Dr Reddy's and Hetero are set to sell a generic version of Lenacapavir, a groundbreaking HIV treatment, at an affordable price of ...Go to article

Cipla is undergoing a leadership change with Umang Vohra stepping down as Global CEO, and Achin Gupta is expected to take over the...Go to article

Russia's Enteromix has developed a cancer vaccine that has shown a 100 success rate in trials and is now awaiting final approval f...Go to article

The article discusses the recent decision to make 33 life-saving drugs, including Daratumumab, Alectinib, and Obinutuzumab, GST-fr...Go to article

The article discusses the Paracetamol market, highlighting DOLO-650 as the top prescribed brand according to industry data, and pr...Go to article

Eris Lifesciences has been issued a GST notice amounting to Rs 17 Crore concerning its deal with Novartis for the drug Zomelis. Th...Go to article